200
Participants
Start Date
October 1, 2023
Primary Completion Date
April 1, 2024
Study Completion Date
August 15, 2024
Silodosin
Silodosin is an oral medication primarily used to treat benign prostatic hyperplasia (BPH) by relaxing the muscles in the prostate and bladder neck to improve urine flow. It belongs to a class of drugs called alpha-1 adrenergic antagonists, which block receptors responsible for muscle contraction in these areas. This action helps relieve symptoms such as difficulty urinating, urgency, and weak urine stream. Silodosin is taken once daily with food and is known for its high selectivity for alpha-1A receptors, contributing to its effectiveness and safety profile
Fatima Jinnah Medical University, Lahore
Fatima Jinnah Medical University
OTHER